A carregar...
Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes
IN BRIEF Sodium glucose cotransporter 2 (SGLT2) inhibitors are a new class of antihyperglycemic agents that lower blood glucose levels in patients with type 2 diabetes. SGLT2 inhibitors have an insulin-independent mechanism of action, acting to inhibit the reabsorption of glucose in the kidney, whic...
Na minha lista:
| Publicado no: | Clin Diabetes |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4299744/ https://ncbi.nlm.nih.gov/pubmed/25653467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/diaclin.33.1.5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|